1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Growth Hormone for Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Human Growth Hormone for Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Human Growth Hormone for Injection by Country/Region, 2018, 2022 & 2029
2.2 Human Growth Hormone for Injection Segment by Type
2.2.1 Water Injection
2.2.2 Powder Injection
2.3 Human Growth Hormone for Injection Sales by Type
2.3.1 Global Human Growth Hormone for Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Human Growth Hormone for Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Human Growth Hormone for Injection Sale Price by Type (2018-2023)
2.4 Human Growth Hormone for Injection Segment by Application
2.4.1 Aldult
2.4.2 Child
2.5 Human Growth Hormone for Injection Sales by Application
2.5.1 Global Human Growth Hormone for Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Human Growth Hormone for Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Human Growth Hormone for Injection Sale Price by Application (2018-2023)
3 Global Human Growth Hormone for Injection by Company
3.1 Global Human Growth Hormone for Injection Breakdown Data by Company
3.1.1 Global Human Growth Hormone for Injection Annual Sales by Company (2018-2023)
3.1.2 Global Human Growth Hormone for Injection Sales Market Share by Company (2018-2023)
3.2 Global Human Growth Hormone for Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Human Growth Hormone for Injection Revenue by Company (2018-2023)
3.2.2 Global Human Growth Hormone for Injection Revenue Market Share by Company (2018-2023)
3.3 Global Human Growth Hormone for Injection Sale Price by Company
3.4 Key Manufacturers Human Growth Hormone for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Growth Hormone for Injection Product Location Distribution
3.4.2 Players Human Growth Hormone for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Growth Hormone for Injection by Geographic Region
4.1 World Historic Human Growth Hormone for Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Human Growth Hormone for Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Human Growth Hormone for Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Human Growth Hormone for Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Human Growth Hormone for Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Human Growth Hormone for Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Human Growth Hormone for Injection Sales Growth
4.4 APAC Human Growth Hormone for Injection Sales Growth
4.5 Europe Human Growth Hormone for Injection Sales Growth
4.6 Middle East & Africa Human Growth Hormone for Injection Sales Growth
5 Americas
5.1 Americas Human Growth Hormone for Injection Sales by Country
5.1.1 Americas Human Growth Hormone for Injection Sales by Country (2018-2023)
5.1.2 Americas Human Growth Hormone for Injection Revenue by Country (2018-2023)
5.2 Americas Human Growth Hormone for Injection Sales by Type
5.3 Americas Human Growth Hormone for Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Growth Hormone for Injection Sales by Region
6.1.1 APAC Human Growth Hormone for Injection Sales by Region (2018-2023)
6.1.2 APAC Human Growth Hormone for Injection Revenue by Region (2018-2023)
6.2 APAC Human Growth Hormone for Injection Sales by Type
6.3 APAC Human Growth Hormone for Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Growth Hormone for Injection by Country
7.1.1 Europe Human Growth Hormone for Injection Sales by Country (2018-2023)
7.1.2 Europe Human Growth Hormone for Injection Revenue by Country (2018-2023)
7.2 Europe Human Growth Hormone for Injection Sales by Type
7.3 Europe Human Growth Hormone for Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Growth Hormone for Injection by Country
8.1.1 Middle East & Africa Human Growth Hormone for Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Human Growth Hormone for Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Human Growth Hormone for Injection Sales by Type
8.3 Middle East & Africa Human Growth Hormone for Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Growth Hormone for Injection
10.3 Manufacturing Process Analysis of Human Growth Hormone for Injection
10.4 Industry Chain Structure of Human Growth Hormone for Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Growth Hormone for Injection Distributors
11.3 Human Growth Hormone for Injection Customer
12 World Forecast Review for Human Growth Hormone for Injection by Geographic Region
12.1 Global Human Growth Hormone for Injection Market Size Forecast by Region
12.1.1 Global Human Growth Hormone for Injection Forecast by Region (2024-2029)
12.1.2 Global Human Growth Hormone for Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Growth Hormone for Injection Forecast by Type
12.7 Global Human Growth Hormone for Injection Forecast by Application
13 Key Players Analysis
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Human Growth Hormone for Injection Product Portfolios and Specifications
13.1.3 Novo Nordisk Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 LillyMedical
13.2.1 LillyMedical Company Information
13.2.2 LillyMedical Human Growth Hormone for Injection Product Portfolios and Specifications
13.2.3 LillyMedical Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 LillyMedical Main Business Overview
13.2.5 LillyMedical Latest Developments
13.3 Genentech
13.3.1 Genentech Company Information
13.3.2 Genentech Human Growth Hormone for Injection Product Portfolios and Specifications
13.3.3 Genentech Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Genentech Main Business Overview
13.3.5 Genentech Latest Developments
13.4 Pfizer Medical
13.4.1 Pfizer Medical Company Information
13.4.2 Pfizer Medical Human Growth Hormone for Injection Product Portfolios and Specifications
13.4.3 Pfizer Medical Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Medical Main Business Overview
13.4.5 Pfizer Medical Latest Developments
13.5 Shanghai United Cell Biological Engineering
13.5.1 Shanghai United Cell Biological Engineering Company Information
13.5.2 Shanghai United Cell Biological Engineering Human Growth Hormone for Injection Product Portfolios and Specifications
13.5.3 Shanghai United Cell Biological Engineering Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Shanghai United Cell Biological Engineering Main Business Overview
13.5.5 Shanghai United Cell Biological Engineering Latest Developments
13.6 EMD Serono, Inc.
13.6.1 EMD Serono, Inc. Company Information
13.6.2 EMD Serono, Inc. Human Growth Hormone for Injection Product Portfolios and Specifications
13.6.3 EMD Serono, Inc. Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 EMD Serono, Inc. Main Business Overview
13.6.5 EMD Serono, Inc. Latest Developments
13.7 Cipla Ltd
13.7.1 Cipla Ltd Company Information
13.7.2 Cipla Ltd Human Growth Hormone for Injection Product Portfolios and Specifications
13.7.3 Cipla Ltd Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cipla Ltd Main Business Overview
13.7.5 Cipla Ltd Latest Developments
13.8 Roche Holding AG
13.8.1 Roche Holding AG Company Information
13.8.2 Roche Holding AG Human Growth Hormone for Injection Product Portfolios and Specifications
13.8.3 Roche Holding AG Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Roche Holding AG Main Business Overview
13.8.5 Roche Holding AG Latest Developments
13.9 Anhui Anke Biotechnology (Group)
13.9.1 Anhui Anke Biotechnology (Group) Company Information
13.9.2 Anhui Anke Biotechnology (Group) Human Growth Hormone for Injection Product Portfolios and Specifications
13.9.3 Anhui Anke Biotechnology (Group) Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Anhui Anke Biotechnology (Group) Main Business Overview
13.9.5 Anhui Anke Biotechnology (Group) Latest Developments
13.10 Eli Lilly
13.10.1 Eli Lilly Company Information
13.10.2 Eli Lilly Human Growth Hormone for Injection Product Portfolios and Specifications
13.10.3 Eli Lilly Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Eli Lilly Main Business Overview
13.10.5 Eli Lilly Latest Developments
13.11 Ipsen
13.11.1 Ipsen Company Information
13.11.2 Ipsen Human Growth Hormone for Injection Product Portfolios and Specifications
13.11.3 Ipsen Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Ipsen Main Business Overview
13.11.5 Ipsen Latest Developments
13.12 LG Life Sciences
13.12.1 LG Life Sciences Company Information
13.12.2 LG Life Sciences Human Growth Hormone for Injection Product Portfolios and Specifications
13.12.3 LG Life Sciences Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 LG Life Sciences Main Business Overview
13.12.5 LG Life Sciences Latest Developments
13.13 Ferring Pharmaceuticals
13.13.1 Ferring Pharmaceuticals Company Information
13.13.2 Ferring Pharmaceuticals Human Growth Hormone for Injection Product Portfolios and Specifications
13.13.3 Ferring Pharmaceuticals Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Ferring Pharmaceuticals Main Business Overview
13.13.5 Ferring Pharmaceuticals Latest Developments
13.14 Teva Pharmaceutical Industries
13.14.1 Teva Pharmaceutical Industries Company Information
13.14.2 Teva Pharmaceutical Industries Human Growth Hormone for Injection Product Portfolios and Specifications
13.14.3 Teva Pharmaceutical Industries Human Growth Hormone for Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Teva Pharmaceutical Industries Main Business Overview
13.14.5 Teva Pharmaceutical Industries Latest Developments
14 Research Findings and Conclusion
| ※参考情報 注射用ヒト成長ホルモン（hGH）は、成長ホルモン（GH）としても知られ、主に脳の下垂体前葉から分泌されるポリペプチドホルモンです。このホルモンは成長や代謝において重要な役割を果たし、特に子供や思春期の青年の成長を促進します。成人においては、筋肉量の維持や脂肪の代謝、骨密度の確保などにも関与しています。注射用ヒト成長ホルモンは、主にさまざまな医療目的で用いられ、欠乏症や特定の病態に対する治療法として広く認知されています。 ヒト成長ホルモンは、その化学構造において29種類のアミノ酸から成り立っており、単純なペプチドでありますが、その作用は非常に複雑です。このホルモン自体は、体内での成長を調節するだけでなく、脂肪の分解や筋肉の合成を促進し、全体的な体組成にも影響を与えます。これにより、成長ホルモンは、スポーツ医学や抗老化医学においても注目されています。 注射用ヒト成長ホルモンの特徴の一つは、その使用形態です。通常、成長ホルモンは皮下注射で投与され、成人と小児いずれでも持続的な効果をもたらすことができます。特に、成長ホルモンの投与は、特定の疾患に対する治療において非常に効果的であり、成長ホルモン欠乏症（GHD）の患者においては、定期的に補充が必要とされます。これに加えて、成長ホルモンは、慢性腎不全、特定の染色体異常、及び思春期遅延の治療に用いることがあります。 ヒト成長ホルモンの種類には、大きく分けて合成成長ホルモンと遺伝子組み換え成長ホルモンがあります。合成成長ホルモンは、動物由来のものであり、過去にはヒトの脳下垂体から抽出されたホルモンが使用されていましたが、感染症のリスクが高いため、現在では主に遺伝子組み換え技術を用いて製造されるホルモンが使用されています。この遺伝子組み換え技術により、より純度の高いホルモンが生成され、使用する際の安全性が格段に向上しました。 注射用ヒト成長ホルモンの用途は多岐にわたりますが、主なものとしては成長ホルモン分泌不全症や代謝異常に伴う症状の改善があります。小児においては、成長ホルモン分泌不全による成長障害の改善を目的に使用され、多くの臨床試験においてその効果が実証されています。成人に対しては、成長ホルモン補充療法が行われ、不足したホルモンを補うことにより、筋力の向上やエネルギー代謝の改善が期待されます。 また、スポーツの分野においては、筋力アップや体重管理の手段として使用されるケースもありますが、これには注意が必要です。成長ホルモンの不正使用は、健康を害するリスクが高く、特にオリンピックなどの競技においてはドーピング禁止薬物に分類されています。したがって、医療的な目的から逸脱した使用については厳格に制限されています。 関連技術としては、成長ホルモンの注射剤製造における生物学的工程や、薬剤の放出制御技術があります。また、成長ホルモンを調節するための生活習慣指導や食事療法も重要です。これらは、成長ホルモンの効果を高め、治療の成果を持続させるために不可欠な要素となります。 さらに、成長ホルモンの研究は活発に進められており、その作用機序や新たな治療応用についての知見が次々に蓄積されています。将来的には、より効果的かつ安全な方法で成長ホルモンの利用が図られることが期待されています。 このように、注射用ヒト成長ホルモンは、その特性や用途において多くの可能性を秘めており、医療現場やスポーツ界において重要な役割を果たすものとなっています。しかし、使用に際しては慎重に考慮する必要がありますし、医療従事者による適切な指導の下で行われるべきです。そうした理解のもと、安全で効果的な治療が実現されることが望まれています。 |
